Reliance Guideline

Reliance Guideline

This guideline is intended to provide recommendations to applicants wishing to submit new registration applications, as well as variations, for reliance review-based evaluation. It represents the Authority’s current thinking on the safety, efficacy and quality of medicines. It is not intended as an exclusive approach. SAHPRA reserves the right to request any additional information to establish the safety, efficacy and quality of a medicine in keeping with the knowledge current at the time of evaluation. Alternative approaches may be used but these should be scientifically and technically justified. The Authority is committed to ensuring that all registered medicines will be of the required safety, efficacy and quality. It is important that applicants adhere to the administrative requirements to avoid delays in the processing and evaluation of applications.

Download latest version

Download archived version (DO NOT USE)
Document Number: SAHPGL-BAU-01
Version: 4
Date Updated: 15/05/2024
File Type: pdf
Category: Guideline
Unit: General ECTD & human medicines